These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 16979749)

  • 21. Increased cell proliferation and contractility of prostate in insulin resistant rats: linking hyperinsulinemia with benign prostate hyperplasia.
    Vikram A; Jena GB; Ramarao P
    Prostate; 2010 Jan; 70(1):79-89. PubMed ID: 19790233
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Is garlic a promising food for benign prostatic hyperplasia and prostate cancer?
    Devrim E; Durak I
    Mol Nutr Food Res; 2007 Nov; 51(11):1319-23. PubMed ID: 17918170
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Acute urinary retention: medical management and the identification of risk factors for prevention.
    Khastgir J; Khan A; Speakman M
    Nat Clin Pract Urol; 2007 Aug; 4(8):422-31. PubMed ID: 17673913
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Relationship between prostatic urethral angle and urinary flow rate: its implication in benign prostatic hyperplasia pathogenesis.
    Cho KS; Kim JH; Kim DJ; Choi YD; Kim JH; Hong SJ
    Urology; 2008 May; 71(5):858-62. PubMed ID: 18343484
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The overlooked cause of benign prostatic hyperplasia: prostatic urethral angulation.
    Cho KS; Kim J; Choi YD; Kim JH; Hong SJ
    Med Hypotheses; 2008; 70(3):532-5. PubMed ID: 17761390
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prostatic stents for the treatment of benign prostatic hyperplasia.
    Vanderbrink BA; Rastinehad AR; Badlani GH
    Curr Opin Urol; 2007 Jan; 17(1):1-6. PubMed ID: 17143103
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Educating patients about lifestyle modifications for prostate health.
    Moyad MA; Lowe FC
    Am J Med; 2008 Aug; 121(8 Suppl 2):S34-42. PubMed ID: 18675616
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Is there evidence of a relationship between benign prostatic hyperplasia and prostate cancer? Findings of a literature review.
    Alcaraz A; Hammerer P; Tubaro A; Schröder FH; Castro R
    Eur Urol; 2009 Apr; 55(4):864-73. PubMed ID: 19027219
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Phenotypic characterization of the infiltrating immune cells in normal prostate, benign nodular prostatic hyperplasia and prostatic adenocarcinoma.
    Hussein MR; Al-Assiri M; Musalam AO
    Exp Mol Pathol; 2009 Apr; 86(2):108-13. PubMed ID: 19111537
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluating use patterns of and adherence to medications for benign prostatic hyperplasia.
    Nichol MB; Knight TK; Wu J; Barron R; Penson DF
    J Urol; 2009 May; 181(5):2214-21; discussion 2221-2. PubMed ID: 19296986
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Insulin and free oestradiol are independent risk factors for benign prostatic hyperplasia.
    Hammarsten J; Damber JE; Karlsson M; Knutson T; Ljunggren O; Ohlsson C; Peeker R; Smith U; Mellström D
    Prostate Cancer Prostatic Dis; 2009; 12(2):160-5. PubMed ID: 18825163
    [TBL] [Abstract][Full Text] [Related]  

  • 32. New histopathological experimental model for benign prostatic hyperplasia: stromal hyperplasia in rats.
    Mori F; Oda N; Sakuragi M; Sakakibara F; Kiniwa M; Miyoshi K
    J Urol; 2009 Feb; 181(2):890-8. PubMed ID: 19095262
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Translation of benign prostatic hyperplasia guidelines into clinical practice.
    Gravas S; Tzortzis V; Melekos MD
    Curr Opin Urol; 2008 Jan; 18(1):56-60. PubMed ID: 18090491
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pathology of benign prostatic hyperplasia.
    Roehrborn CG
    Int J Impot Res; 2008 Dec; 20 Suppl 3():S11-8. PubMed ID: 19002119
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differences in initial benign prostatic hyperplasia management between primary care physicians and urologists.
    Hollingsworth JM; Hollenbeck BK; Daignault S; Kim SP; Wei JT
    J Urol; 2009 Nov; 182(5):2410-4. PubMed ID: 19765742
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Risk factors for lower urinary tract symptoms suggestive of benign prostatic hyperplasia in a community based population of healthy aging men: the Krimpen Study.
    Kok ET; Schouten BW; Bohnen AM; Groeneveld FP; Thomas S; Bosch JL
    J Urol; 2009 Feb; 181(2):710-6. PubMed ID: 19091352
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Practice patterns in benign prostatic hyperplasia surgical therapy: the dramatic increase in minimally invasive technologies.
    Yu X; Elliott SP; Wilt TJ; McBean AM
    J Urol; 2008 Jul; 180(1):241-5; discussion 245. PubMed ID: 18499180
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The expanding role of epigenetics in the development, diagnosis and treatment of prostate cancer and benign prostatic hyperplasia.
    Dobosy JR; Roberts JL; Fu VX; Jarrard DF
    J Urol; 2007 Mar; 177(3):822-31. PubMed ID: 17296351
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Exercise and the prostate: can you run away from trouble?
    Harv Mens Health Watch; 2001 May; 5(10):1-3. PubMed ID: 11410449
    [No Abstract]   [Full Text] [Related]  

  • 40. [Epidemiology of benign prostatic hypertrophy by matched pair analysis (author's transl)].
    Araki H
    Nihon Hinyokika Gakkai Zasshi; 1981 Nov; 72(11):1477-91. PubMed ID: 6175784
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.